A composition for prevention and treatment of Early Mortality Syndrome (EMS) shrimp to replace antibiotics obtain from process creating a basic mixture by mixing a complex composition with mixing ingredients, then stirring the basic mixture for 1 hour, and adjusting the pH to 6.5-7.5 and leaving it for one day at a temperature of 30? C.-35? C.; wherein the complex composition including 10%-15% by weight of a turkey tail mushroom extract and 10%-15% by weight of a chitosan; in which mixing ingredients consisting of a carboxymethyl cellulose solution 0.375%, a alginate solution 0.375%, a potassium citrate solution, a AgNO.sub.3 solution 0.37%, a Cu(NO.sub.3).sub.2 solution 0.723%, a Zn(NO.sub.3).sub.2 solution 3.085%, Co(NO.sub.3).sub.2 solution 0.746%, a Fe(NO.sub.3).sub.3 solution 2.5%, a glycerin ingredient, a vitamin E, a tartrazine ingredient 1%, a K.sub.2HPO.sub.4 solution 15%, a mixture extracts/essential oils, and an other ingredient.

A method for producing full spectrum hemp extract comprising extracting substances from cannabis-based green material that are soluble in an extraction solvent and collecting an extract that includes the extraction solvent distilling at least a portion of the extraction solvent which results in a concentrate that is not distilled off, removing at least a portion of water soluble substances from the concentrate by partitioning the at least a portion of water soluble substances into an aqueous phase and a remainder of substances from the concentrate into a partitioned concentrate, heating the partitioned concentrate to evaporate the nonpolar solvent and to yield a crude oil, degassing the crude oil by heating it which results in a degassed crude oil, performing a first pass distillation at about 150? C. and collecting a first residue, performing a second and third pass distillation at about 170? C. and about 185? C., and collecting a distillate from same.

The invention discloses a composition comprising Cyperus rotundus extract and Passiflora edulis extract comprising piceatannol, scirpusin B, scirpusin A, cyperusphenol A and cyperusphenol B, standardized to contain 6-10% w/w total stilbenes and a process of preparing the composition thereof. The invention also discloses the use of the above mentioned composition in enhancing energy expenditure in mammalian adipose cellular systems by the conversion of white adipose tissues to brown adipose tissues, inhibition of adipogenesis and for preventing weight gain in mammals.

The present invention discloses a process for the purification of Mitragynine, particularly discloses purification of Mitragynine from the crude extracts, for the pharmaceutical preparations. More particularly, the present invention discloses purification of Mitragynine using weak acid and weak base. The obtained purified Mitragynine is with fewer impurities.

A purified lipid-based solution including cannabinoids is manufactured by providing a lipid solution including an array of triglycerides, cannabinoids and water soluble contaminants. Adding water to the lipid solution to create a mixture and heating the mixture in a pressure vessel to a temperature above the melting point of the lipid solution. The mixture is agitated to dissolve the water soluble contaminants and electrocoagulated. The mixture is cooled to cause the triglycerides and cannabinoids to solidify. The water is separated from the mixture to remove water soluble contaminants, precipitated contaminants, suspended solids and colloids from the mixture to yield a purified lipid solution.

The present invention relates to inventive novel industrialized method for preparing purified extract containing more abundant active ingredients such as catalpol derivatives from the extract of Pseudolysimachion rotundum var subintegrum than that prepared by the conventional preparation method disclosed in the prior art and the therapeutics or functional health food comprising the purified extract for treating and preventing inflammatory, allergic or asthmatic disease. The purified extract showed more potent anti-inflammatory, anti-allergy and anti-asthma activity than that prepared by the conventional preparation method disclosed in the prior art through various in vivo tests such as inhibition test on the reproduction of eosinophil, the release of immunoglobulin and inflammatory chemokines in plasma and bronchoalveolar fluid as well as the suppression of airway hyperresponsiveness and goblet cell hyperplasia in a OVA-sensitized/challenged mouse model.

Disclosed embodiments include systems and methods for obtaining desired organic compounds from harvested biomass. Some examples include an extraction vessel and a distillery system, where the extraction vessel is configured to wash harvested biomass with a process solvent to obtain a liquid extract, and where the distillery system is configured to distill the extract to separate the process solvent from the extract and obtain a distillate from the extract. Some embodiments additionally include a speedloader configured to load harvested biomass into the extraction vessel and a discharge gantry configured to remove processed biomass from the extraction vessel. In some embodiments, the extraction vessel, distillery system, speedloader, and discharge gantry are mobile and can be deployed in field at a harvest location.

A method for extracting flavone aglycones in Chrysanthemum morifolium is provided. The method includes: (a) immersing a Chrysanthemum morifolium raw material in water or an aqueous solution to perform an immersion procedure for 3.5 hours or more to obtain an immersion sample; and (b) adding an extraction solvent to the immersion sample to perform an extraction procedure 5-60 minutes to obtain an extract. The Chrysanthemum morifolium raw material includes at least one of the following parts of Chrysanthemum morifolium: whole plant, roots, stems, leaves and flowers.

The present invention relates to inventive novel industrialized method for preparing purified extract containing more abundant active ingredients such as catalpol derivatives from the extract of Pseudolysimachion rotundum var subintegrum than that prepared by the conventional preparation method disclosed in the prior art and the therapeutics or functional health food comprising the purified extract for treating and preventing inflammatory, allergic or asthmatic disease. The purified extract showed more potent anti-inflammatory, anti-allergy and anti-asthma activity than that prepared by the conventional preparation method disclosed in the prior art through various in vivo tests such as inhibition test on the reproduction of eosinophil, the release of immunoglobulin and inflammatory chemokines in plasma and bronchoalveolar fluid as well as the suppression of airway hyperresponsiveness and goblet cell hyperplasia in a OVA-sensitized/challenged mouse model.

Plant extracts, compositions, pharmaceutical compositions and methods of making and using the same are provided herein. The compositions comprise -tocotrienol (GT3) and -tocotrienol (DT3) in ratios wherein the DT3 is predominate. The compositions are useful for radioprotection and radiomitigation in subjects in need thereof.